Atlas Trials

Rechallenge of BRAF +/- MEK Inhibitors Following an Adverse Event in Patients With Cancer

Clinical trial NCT05080361 · UNKNOWN

Trial details

NCT number
NCT05080361
Sponsor
University Hospital, Caen
Status
UNKNOWN
Study type
OBSERVATIONAL
Cancer
Start date
2011-01-01
Primary completion
2021-03-01
Enrollment
16000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.